Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

BORIS DOI
Official URL
Publisher DOI
PubMed ID
32969160
Description
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
Date of Publication
2020-12
Publication Type
Article
Subject(s)
Keyword(s)
COVID-19 childhood adolescent and young adult (CAYA) cancer survivors late effects of cancer treatment
Language(s)
en
Contributor(s)
Verbruggen, Lisanne C
Wang, Yuehan
Armenian, Saro H
Ehrhardt, Matthew J
van der Pal, Helena J H
van Dalen, Elvira C
van As, Jorrit W
Bardi, Edit
Baust, Katja
Berger, Claire
Castagnola, Elio
Devine, Katie A
Gebauer, Judith
Marchak, Jordan Gilleland
Glaser, Adam W
Groll, Andreas H
Haeusler, Gabrielle M
den Hartogh, Jaap
Haupt, Riccardo
Hjorth, Lars
Kato, Miho
Kepák, Tomáš
Koopman, Maria M W Rianne
Langer, Thorsten
Maeda, Miho
Michel, Gisela
Muraca, Monica
Nathan, Paul C
van den Oever, Selina R
Pavasovic, Vesna
Sato, Satomi
Schulte, Fiona
Sung, Lillian
Tissing, Wim
Uyttebroeck, Anne
Mulder, Renée L
Skinner, Roderick
Hudson, Melissa M
Kremer, Leontien C M
Additional Credits
Series
Pediatric blood & cancer
Publisher
Wiley-Liss
ISSN
1545-5009
Access(Rights)
restricted
Show full item